Naveen Pemmaraju/LinkedIn
Jul 5, 2025, 15:31
Naveen Pemmaraju: Management of BPDCN in the Setting of Severe Co-Morbidities
Naveen Pemmaraju, Professor, Department of Leukemia at MD Anderson Cancer Center, shared on LinkedIn:
“Proud to share our group’s latest paper just out in Leukemia & Lymphoma — led by our superstar MD Leukemia Fellow Dr Jen Croden — on management of BPDCN in the setting of severe co-morbidities.”
Title: Managing BPDCN in the context of severe hyperbilirubinemia: a case study
Authors: Jennifer Croden, Naveen Pemmaraju, Kelley Fliehler, Arsemen Brown, Wei Wang, Hagop Kantarjian, Francisco Vega & Tapan Kadia
Read the Full Article.
More posts featuring Naveen Pemmaraju on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 5, 2025, 20:31
Jul 5, 2025, 20:15
Jul 5, 2025, 20:00
Jul 5, 2025, 19:18
Jul 5, 2025, 18:52
Jul 5, 2025, 18:38